Beneath the surface of yet another venture capital fund closure lies a signal that the crypto industry is inclined to dismiss. Chemistry Ventures, a firm with a track record in fintech, has raised $500 million for its second fund. The headline number is impressive. The managing partner’s explicit comment, however, is what should give us pause: the fund prefers fintech over cryptocurrency, viewing the latter as less stable and traditional capital channels as more attractive. This is not a casual remark. It is a data point that confirms a macro shift in risk appetite.
To understand why this matters, we must first step back and admit something uncomfortable. The crypto industry has become addicted to venture capital as a lifeblood. From 2020 to 2022, VC money flooded into every token sale and infrastructure play, inflating valuations and creating a dependency that few projects have since shaken off. Chemistry Ventures is not a crypto-native fund. It represents the broader pool of institutional capital that sits on the sidelines, watching. When a $500 million fund explicitly says it is turning away from crypto, the signal is not about Chemistry Ventures alone. It is about the perception of risk among the limited partners—the pension funds, endowments, and family offices that ultimately decide where capital flows.
Let’s dissect the mechanics. The managing partner’s statement reveals a preference for “stable and traditional” channels. In practice, that means regulated payment rails, lending platforms with clear legal frameworks, and software companies that generate recurring revenue. These are not sexy. But they are predictable. In a world where interest rates have normalized and the memory of the Terra collapse remains fresh, predictability is a premium asset. During my work auditing DeFi protocols in 2022, I saw firsthand how quickly a seemingly robust liquidation engine could unravel when oracles lagged by seconds. The structural fragility of many crypto projects is not a bug—it is a feature of the experimental design. Traditional fintech companies, by contrast, operate within known regulatory sandboxes where failure is expensive but rarely catastrophic. Capital flows to the path of least regulatory friction, and right now, fintech offers that path.
The $500 million figure itself is not extraordinary in absolute terms. But it is a positioning bet. Chemistry Ventures is signaling to its portfolio companies and to the market that it will back companies that solve real-world problems without the speculative overlay of tokens. This directly challenges the narrative that “crypto is the future of finance.” The future, in Chemistry’s view, looks a lot like the present—only faster, cheaper, and more compliant. This is not a rejection of innovation; it is a rejection of unregulated experimentation as the primary vehicle for innovation.
Now, let’s examine the contrarian angle. Many in crypto will interpret this news as a bearish signal, reinforcing the idea that institutions are abandoning the space. I argue the opposite: this capital reallocation is a healthy, necessary correction. The 2021 bull market created an illusion of abundance. Every Layer 2, every DeFi protocol, every NFT collection received funding not because it solved a real problem, but because the narrative of easy returns attracted liquidity. That liquidity was always borrowed from the future. When the music stopped, the debt came due. Chemistry Ventures’ shift is a reminder that capital is not infinite. It forces projects to ask themselves: “If we cannot raise VC money, can we build something that people will pay for?” That question, uncomfortable as it is, is the only one that separates sustainable projects from Ponzi-like structures.
Consider the empirical evidence. Since the peak of 2021, we have seen a steady decline in crypto VC activity. According to Messari data, global crypto VC funding dropped from $31 billion in 2021 to roughly $10 billion in 2023. That 68% decline is not just the result of a bear market. It reflects a structural reassessment: VCs realized that many crypto business models depend on token price appreciation rather than user utility. When token prices fall, the user base evaporates. Tracing the hidden vulnerabilities in the code of these projects often reveals the same pattern: the revenue model is tied to speculative volume. Chemistry Ventures is calling out that vulnerability implicitly.
But there is a deeper layer here—one that touches on our own industry’s tendency to fragment its own resources. Over the past three years, I have observed the proliferation of Layer 2 solutions, each promising to scale Ethereum while instead slicing liquidity into ever-thinner shards. The same pattern is now playing out at the capital level. Multiple VCs are raising funds but narrowing their focus. Chemistry Ventures is not an outlier; it is a symptom. The industry is experiencing a liquidity fragmentation of capital, and the result is that fewer projects will receive meaningful funding. This is not necessarily bad. It means only the most resilient—those with genuine user demand, clear unit economics, and regulatory clarity—will survive. Quietly securing the layers beneath the hype is the work that matters now.
From a user perspective, this shift has a direct consequence: the cost of using crypto applications will rise for projects that fail to secure sustainable funding. During my deep dive into Uniswap V2’s slippage mechanics in 2020, I calculated that migrating from ERC-721 to ERC-1155 could reduce gas costs by 40% for gamers. That kind of micro-optimization becomes critical when VC money dries up. Projects cannot afford to subsidize user transactions indefinitely. They must either pass costs to users or build revenue models that don’t rely on token inflation. The era of subsidized usage is ending, and Chemistry Ventures’ fund is the latest confirmation.
Let’s also address the elephant in the room: the narrative itself. Some will argue that Chemistry Ventures is simply late to the party—that fintech is mature and crypto is the next frontier. But that argument ignores the fact that “fintech vs. crypto” is a false dichotomy. Many fintech companies—Stripe, PayPal, Square—are already integrating crypto infrastructure. The boundary is blurring. What Chemistry Ventures is really saying is that they prefer companies that solve a well-defined problem with a clear regulatory path, regardless of whether they use blockchain or not. If a crypto project can demonstrate that, it will still attract capital. The problem is that most crypto projects cannot. Redefining what ownership means in the digital age is a noble goal, but it does not put food on the table for LPs who need predictable returns.
I am not advocating for panic. I am advocating for clarity. The next 12 months will separate projects that generate actual revenue from those that rely on narrative. For the crypto ecosystem, this capital reallocation might be the catalyst we needed to mature. It forces us to ask: “Are we building speculative instruments or functional infrastructure?” The answer to that question will determine whether the next wave of VC funding returns to crypto—or whether it stays permanently with fintech.
As I finish this analysis, I recall a conversation with a smart contract auditor who told me: “The safest code is the code that never needs to be upgraded because it just works.” Similarly, the safest capital is the capital that flows to projects that don’t need constant VC injections because they have real users paying real fees. Chemistry Ventures’ $500 million fund is not a threat. It is a mirror.
Building trust through rigorous, unseen diligence is my approach, and that diligence tells me this: the crypto industry must stop expecting VCs to subsidize its growth. We must build things people will pay for, not things people will speculate on. Until we do, the capital will continue to flow toward fintech—and it will be deserving.